Cartesian Therapeutics (RNAC) Change in Taxes (2021 - 2022)
Cartesian Therapeutics (RNAC) posted quarterly Change in Taxes of -$321000.0 for Q3 2022, down 102.03% year-over-year from $15.8 million in Q3 2021, and down 32200.0% quarter-over-quarter from $1000.0 in Q2 2022.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Change in Taxes (2021 - 2022) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Change in Taxes for 2 consecutive years, with -$321000.0 the latest figure, recorded in Q3 2022.
- In Q3 2022, Change in Taxes fell 102.03% year-over-year to -$321000.0; the TTM figure through Jun 2023 stood at -$321000.0 (down 200.0% YoY), while the FY2022 annual figure was -$601000.0, down 200.0% from the prior year.
- Change in Taxes declined to -$321000.0 in Q3 2022 per RNAC's latest filing, from $1000.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $15.8 million in Q3 2021 and bottomed at -$15.2 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Cartesian Therapeutics | 271.98 Mn | 271.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -321,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | -281,000.00 |
| Dec 31, 2021 | -15.23 Mn |
| Sep 30, 2021 | 15.83 Mn |